Contracts › 75A50124F61009
75A50124F61009: The Purpose of This Requirement Is to Provide Medical Countermeasures (MCMS), Such As Vaccines and Adjuvants, for Pandemic Preparedness and Response or As Required in Response to a Hhs Designated
Awarded to Sanofi Vaccines Us Inc. by Office of Assistant Secretary for Preparedness and Response.
$1.5Mobligated
$1.5Mpotential value
21 May 2027current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75A50124F61009 |
|---|---|
| Vehicle | 75A50122D00003 |
| Awardee | Sanofi Vaccines Us Inc. |
| Awarding agency | Office of Assistant Secretary for Preparedness and Response |
| Awarding office | BARDA - ASPR / DAAPPO / BARDA DCMA |
| NAICS | 541714 Research and Development in Biotechnology (Except Nanobiotechnology) |
| PSC | AN12 Health R&D Services; Health Care Services; Applied Research |
| Place of performance | PA |
| Period of performance | 22 February 2024 to 21 May 2027 |
| Potential end | 21 May 2027 |
| Estimated recompete solicitation | ~Q4 2026 (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 03 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541714 contracts · All expiring contracts · USASpending record